Celularity Second Quarter 2025 Earnings: US$1.02 loss per share (vs US$0.30 loss in 2Q 2024)

September 01, 2025

Simply Wall St

Celularity (NASDAQ:CELU) Second Quarter 2025 Results

Key Financial Results

Revenue: US$5.74m (down 53% from 2Q 2024).
Net loss: US$24.5m (loss widened by 278% from 2Q 2024).
US$1.02 loss per share (further deteriorated from US$0.30 loss in 2Q 2024).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

earnings-and-revenue-history — NasdaqCM:CELU Earnings and Revenue History September 1st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Celularity shares are up 2.6% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 3 warning signs for Celularity (2 shouldn't be ignored!) that you need to be mindful of.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

mitchell_lawler

Micron (MU) is booming, and it still doesn't look ‘expensive’ based on next year's earnings. So why does our own valuation say it could be worth 40% less?

zoe_vi5fn10h

A low price to earnings ratio at the top of the cycle is a warning rather than a bargain, and a terrifyingly high one at the bottom is often the entry point

darius_xnnrd10h

Memory used to have a dozen participants racing each other into oversupply, and now it has three. High bandwidth memory is qualified into customer designs years ahead, sold under long-term agreements, and is far harder to switch away from than commodity DRAM.